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Emerging evidence suggests that reactive oxygen (ROS) and nitrogen (RNS) species can contribute to diverse signalling pathways of
inflammatory and tumour cells. Cucurbitacins are a group of highly oxygenated triterpenes. Many plants used in folk medicine to
treat cancer have been found to contain cucurbitacins displaying potentially important anti-inflammatory actions. The current
study was designed to investigate the anti-ROS and -RNS eﬀects of cucurbitacin L 2-O-β-glucoside (CLG) and the role of
these signaling factors in the apoptogenic eﬀects of CLG on human colon cancer cells (HT-29). This natural cucurbitacin was
isolated purely from Citrullus lanatus var. citroides (Cucurbitaceae). The results revealed that CLG was cytotoxic to HT-29. CLG
increased significantly (P < 0.05) RNA and protein levels of caspase-3 in HT-29 cells when verified using a colorimetric assay and
realtime qPCR, respectively. The results showed that lipopolysaccharide/interferon-gamma (LPS/INF-γ) increased nitrous oxide
(NO) production inR AW264.7macrophages, whereas N(G)-nitro-L-argininemethyl ester (L-NAME) and CLG curtailed it. This
compound did not reveal any cytotoxicity on RAW264.7 macrophages and human normal liver cells (WRL-68) when tested using
the MTT assay. Findings of ferric reducing antioxidant power (FRAP) and oxygen radical absorption capacity (ORAC) assays
demonstrate the antioxidant properties of CLG. The apoptogenic property of CLG on HT-29 cells is thus related to inhibition of
reactive nitrogen and oxygen reactive species and the triggering of caspase-3-regulated apoptosis.
1. Introduction
The attractive association between chronic inflammation
and cancer has been a fertile field for the growth of biomed-
ical research. In particular, the development of colon cancer
is a distinctive situation in which inflammatory conditions
such as ulcerative colitis increase the risk of cancer by 20-fold
[1, 2]. The presence of certain inflammationmarkers, such as
the C-reactive protein circulating in the blood, is correlated
with an increased risk of colon cancer [3]. In addition, over-
expression of proinflammatory enzymes, such as inducible
nitric oxide synthase and cyclooxygenase-2, has been
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reported in human colon cancer and in an azoxymethane-
induced colon cancer model in rats [4, 5]. More importantly,
selective inhibitors of these inflammatory genes are eﬀective
in inhibiting experimental colon cancer of rodents [6, 7].
Epithelial cells express reactive nitrogen and oxygen
species (free radicals) in response to inflammatory cytokines
and the bacterial endotoxins. The initiation by NADPH
(nicotinamide adenine dinucleotide phosphate) oxidase is
always required for the production of free radicals. These
free radicals were activated upon translocation of several
cytosolic proteins to themembrane-bound complex carrying
cytochrome c. Moreover, the activation of NADPH oxidase
can be caused by microbial products such as lipopolysac-
charide and lipoproteins, by IFN-γ (interferon-gamma), by
IL-8 (interleukin-8), or by IgG binding to Fc-receptors. The
primary product of the reaction catalyzed by the NADPH
oxidase is superoxide (O2
−), which can be converted to H2O2
by superoxide dismutase (SOD), to hydroxyl radicals (.OH)
and hydroxyl anions (OH−) by the iron-catalyzed Haber-
Weiss reaction, or after dismutation to H2O2, to hypochlor-
ous acid (HOCl) and chloramines by myeloperoxidase [8].
Depending on the cell type, various downstream signalling
pathways are also involved in the transcriptional regulation
of ROS and RNS. This phenomenon of cellular inflammatory
response also takes place on other types of cells. This is also
tested experimentally in cancer and inflammation models.
Epithelial cells have been implicated in many of these exper-
iments, as they are directly involved with the inflammatory
response [9–12]. One of the important roles of these cells
is the production of various cytokines, reactive oxygen
and nitrogen species, growth factors, and chemokines as a
response to activation signals such as chemical mediators,
cytokines, and bacterial lipopolysaccharide [13]. Although
the bioactive molecules produced by macrophages have
valuable outcomes in inflammation, these molecules were
also shown to have unfavorable and damaging eﬀects.
Hence, the modulation of these products provides a tar-
get for controlling inflammatory and malignant diseases
[3].
Wild melon (Citrullus lanatus var. citroides; belonging
to the Cucurbitaceae family) is a low climbing, hairy,
and annual plant. Cucurbit plants were used actively as
traditional herbal remedies for various diseases including
cancer [14–17]. Cucurbit plants have demonstrated anti-
inflammatory, antitumor, liver protective, and immune-
regulatory activities. This family is also known to contain
several bioactive compounds such as cucurbitacins, triter-
penes, sterols, and alkaloids. Plants containing cucurbitacins
were early recognized in folk medicine to have biological
value. Many plants used in folk medicine to treat inflam-
matory conditions have been found to contain triterpenoids
displaying potentially important anti-inflammatory actions,
in diﬀerent in vivo and in vitro assays, as well as inhibition
of hydrolytic enzyme activity and lipid peroxidation [18]. In
this regard, the root extract of Wilbrandia ebracteata (Cucur-
bitaceae), a plant commonly used in Brazil to treat rheumatic
disease, was reported to contain several cucurbitacins [19].
There are limited studies on the chemopreventive eﬀect and
the mechanism of action of CLG. Therefore, the present
study attempts to understand the inhibitory eﬀects of CLG
on reactive nitrogen and oxygen species as an explanation
for the apoptogenic eﬀects of this natural cucurbitacin
in colon cancer cells (HT-29). Based on our studies, the
anti-inflammatory and antioxidant properties of CLG may
be regarded as a key attribute for its role against colon
tumorigenesis.
2. Materials and Methods
2.1. Cell Lines and Reagents. All cell lines were obtained from
American type culture collection (ATCC). Dulbecco’s Mod-
ified Eagle Medium (DMEM) both with and without phenol
red, phosphate buﬀered saline and Hanks’ balanced salt
solution (HBSS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphen-
yltetrazoliumbromide (MTT), phosphate buﬀered saline
(PBS), and Griess reagent were from Invitrogen (Carlsbad,
USA). Fetal bovine serum (FBS), LPS from E. coli serotype
0111 : B4, L-NAME, dimethylsulfoxide (DMSO), and
sodium nitrite were obtained from Sigma (St. Louis, USA).
IFNγ was from BD Biosciences (New Jersey, USA). All other
chemicals and reagents used were of HPLC grade.
2.2. Isolation of Cucurbitacin L 2-O-β-Glucoside. Citrullus
latanus var. citriode was collected fromAL-Musawwarat area,
Northern Sudan, on February 2008. The voucher specimen
was identified by Dr. Wai’l S. Abdalla, a senior botanist at
the herbarium of Medicinal and Aromatic Plants Research
Institute (MAPRI), Khartoum, Sudan, where the specimen
was also deposited and coded with CL2-8. CLG was isolated
from the dried fruit pulp according to the method described
earlier [20]. The structure of this compound was established
by spectroscopic methods and by comparison with the
previous reported works [20–22]. Purity of the compound
was found to be 98.5% using LC/MS.
2.3.3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bro-
mide Cell Viability Assay on Normal and Cancer Cells.
All the cells were maintained in a 37◦C incubator with
5% CO2 saturation. Human hepatocellular carcinoma cells
(HepG2), colon adenocarcinoma cells (HT-29), and normal
hepatic cells (WRL-68) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), whereas non-small-cell
lung cancer cells (A549) and prostate adenocarcinoma cells
(PC3) were maintained in RPMI-1640 medium. Both media
were supplemented with 10% fetal bovine serum (FBS),
100 units/mL penicillin, and 0.1mg/mL streptomycin.
Diﬀerent cell types from above were used to determine
the cytotoxic eﬀects of CLG and paclitaxel on cancer and
normal cells using the MTT assay. For measurement of cell
viability, cells were seeded at a density of 1 × 105 cells/mL
in a 96-well plate and incubated for 24 h at 37◦C and 5%
CO2. Cells were treated and incubated for 24 h. After 24 h,
MTT solution at 2mg/mLwas added for 4 h. Absorbance was
measured at 570 nm. Results were expressed as a percentage
of control giving percentage cell viability after 24 h exposure
to test agents. The potency of cell growth inhibition for the
tested compounds was expressed as an EC50 value, defined
as the concentration that caused a 50% loss of cell growth.
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Viability was defined as the ratio (expressed as a percentage)
of absorbance of treated cells to untreated cells.
2.4. Chromatin Condensation Assay. For detection of apop-
totic cells, apoptotic nuclear morphology was observed
by staining with Hoechst 33342. Cells at a density 1 ×
105 cells/mL were seeded on a 96-well culture plate. Cells
were treated with IC50 of CLG and incubated for 24 and 48 h.
After treatment, cells were washed with PBS and stained with
Hoechst 33342 (1mM), and plates were analyzed using the
ArrayScan HCS system (Cellomics, PA, USA).
2.5. Colorimetric Assays of Caspase-3. The colorimetric pro-
tease assay of caspase-3 provides a simple and convenient
means for quantifying the enzyme activity that recognizes the
amino acid sequence, DEVD (A synthetic tetrapeptide, (Asp-
Glue-Val-Asp), which is the upstream amino acid sequence
of the caspase-3 (cleavage site), coupled with p-nitroanilide,
which is released upon substrate cleavage. This assay was
performed using the commercial kit ApoTarget (Code:
KHZ0022: BioSource International, Inc., USA). 1 × 105
cells/mL were treated with IC50 of CLG and incubated for
24 and 48 h while untreated cells acted as control. The cells
were lysed by the addition of 50 μL of chilled Cell Lysis Buﬀer
and incubated on ice for 10min. The resulting cell lysate was
centrifuged for 1min at 10, 000 ×g, and the supernatant was
collected. Fifty microliters of 2X Reaction Buﬀer (containing
10mM DTT) was added to each sample. Then 5 μL of
DEVD-pNA (caspase-3 substrate) was added and incubated
in the dark at 37◦C for 1 h. At the end of the incubation
period, the samples were read at 405 nm in a microplate
reader (TECAN, SunriseTM, Ma¨nnedorf, Switzerland). Data
was presented as optical density (405 nm; mean± SD).
2.6. Real-Time Polymerase Chain Reaction. Total RNA was
extracted using RNeasy Mini Kit following the manufac-
turer’s instructions (Qiagen, Germantown, Maryland, USA).
RNA concentrations were quantified using a spectro-
photometer (Smart Spec, Bio-Rad. RNA quality and inte-
grity were determined via the A260/A280 ratio and agarose
gels electrophoresis, respectively. cDNA was synthesized
with Revert Aid H Minus M-muLV reverse transcriptase
(Biometra, Goettingen, Germany). Real-time RT-PCR was
performed using an ABI 7700 Prism Sequence Detection
System and TaqMan primer probes (Applied Biosystems,
Foster City, CA). The total reaction volume was 20 μL:
2 μL cDNA, 10 μL SYBR Premix ExTaq, 0.4 μL of each
primer (10 μM; caspase-3 primer; sense, 5′-TTAATAAAGG-
TATCCATGGAGAACACT-3′; antisense, 5′-TTAGTGATAA-
AAATAGAGTTCTTTTGTGAG-3′), and 7.2 μL ultrapure
water. Cycle parameters were as follows: activation at 95◦C
for 30 s, 40 cycles of denaturation at 95◦C for 5 s, and then
annealing and extension at 60◦C for 30 s. Glyceraldehyde-
3-phosphate dehydrogenase gene (GAPDH) was used as an
internal control for each sample. The primers for GAPDH
were 5′-GGTGGTCTCCTCTGACTTCAACA-3′ (sense) and
5′-GTTGCTGTAGCCAAATTCGTTGT-3′ (antisense). PCR
products were detected using gel electrophoresis.
2.7. Eﬀect of CLG on Nitric Oxide Production
2.7.1. Cell Culture and Stimulation. The murine mono-
cytic macrophages cell line (RAW 264.7) was maintained
in DMEM supplemented with 10% FBS, 4.5 g/L glucose,
sodium pyruvate (1mM), L-glutamine (2mM), strepto-
mycin (50 μg/mL), and penicillin (50U/mL) at 37◦C and
5% CO2. Cells at confluency of 80–90% were centrifuged at
120×g at 4◦C for 10min, and cell concentration was adjusted
to (2 × 106) cells/mL, whereby the cell viability was always
more than 90%, as determined by trypan blue exclusion.
A total of 50 μL of cell suspension was seeded into a tissue
culture grade 96-well plate (4× 105 cells/well) and incubated
for 2 h at 37◦C, 5% CO2 for cell attachment. Then, the cells
were stimulated by using 100U/mL of IFN-γ and 5 μg/mL
of LPS with or without the presence of CLG and L-NAME
(250 μM) tested at the final volume of 100 μL/well. DMSO
was used as vehicle, where the final concentration of DMSO
was maintained at 0.1% of all cultures. Cells were further
incubated at 37◦C, 5%CO2 for 20 h. The culture supernatant
was subjected to Griess assay for nitrite determination, and
the cells remaining in the well were tested for cell viability
assay by using MTT reagent.
2.7.2. Griess Assay. To evaluate the inhibitory activity of
CLG and L-NAME on nitric oxide (NO) production, culture
media was assayed using Griess reaction [23]. Briefly, an
equal volume of Griess reagent (1% sulphanilamide and
0.1% N-(l-naphthyl)-ethylene diaminedihydrochloride, dis-
solved in 2.5% H3PO4) was mixed with the culture super-
natant, and colour development was measured at 550 nm
using a microplate reader (SpectraMax Plus, Molecular
Devices Inc., Sunnyvale, CA, USA). The amount of nitrite in
the culture supernatant was calculated from a standard curve
(0–100 μM) of sodium nitrite freshly prepared in deionized
water. Percentage of the NO inhibition was calculated by
using nitrate level of IFN-γ/LPS-induced group as the
control,
NO inhibitory (%)
=
[
NO2
−]
control −
[
NO2
−]
sample[
NO2
−]
control
× 100%.
(1)
2.7.3. Cell Viability of RAW 264.7 Macrophage. The cytotox-
icity of CLG on cultured cells was determined by assaying
the reduction of MTT reagents to formazan salts [24]. After
removing the supernatant, the MTT reagents (5mg/mL,
dissolved in sterile PBS, pH 7.0) were added into each
well. The cells remaining were incubated at 37◦C for 4 h,
and the formazan salts formed were dissolved by adding
100 μL of 100% DMSO in each well. The absorbance was
then measured at 570 nm using SpectraMax Plus microplate
reader (Molecular Devices, USA). The percentage of cell
viability was calculated by using the cell viability of IFN-
γ/LPS-induced group as the control,
cell viability (%)
= ODcontrol −ODsample
ODcontrol
× 100%.
(2)
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Table 1: Eﬀect of CLG and paclitaxel on diﬀerent cells type expressed as EC50 values in MTT assay.
Cell line Tissue of human origin
Compound EC50 ± SD (μg/mL)
Cucurbitacin L 2-O-β-Glucoside Paclitaxel
A549 Non-small-cell lung cancer >200 5.81± 1.03
PC-3 Human prostate carcinoma >200 0.08± 0.03
HepG2 Hepatocellular carcinoma >200 1.18± 0.24
HT-29 Colon adenocarcinoma 79.76± 2.34 0.06± 0.02
WRL-68 Normal hepatic cells >200 0.10± 0.05
2.8. Antioxidant Capacity of CLG
2.8.1. Oxygen Radical Absorbance Capacity. The oxygen
radical absorbance capacity (ORAC) assay was done to test
the antioxidant capacity of CLG based on the procedure
described earlier with slight modifications [25]. Briefly
175 μL of the sample/blank was dissolved with PBS at
concentrations of 160 μg/mL, pH 7.4, 75mM, and serial
dilutions for the Trolox standards were prepared accordingly.
ORAC assay was performed in a 96-well black microplate
with 25 μL of samples/standard/positive control and 150 μL
of fluorescence sodium salt solution, followed by 25 μL of
2,20-azobis (2-amidinopropane) dihydrochloride (AAPH)
solution after 45-minute incubation at 37◦C (200 μL total
well volume). Fluorescence was recorded until it reached zero
(excitation wavelength at 485 nm, while emission wavelength
at 535 nm) in a fluorescence spectrophotometer (Perkin-
Elmer LS 55), equipped with an automatic thermostatic
autocell holder at 37◦C. The positive control was Quercetin,
and the negative control was blank solvent/PBS. Data were
collected every 2min for a duration of 2 h. Results were
calculated using the diﬀerences of areas under the fluorescein
decay curve (AUC) between the blank and the sample and are
expressed as Trolox equivalents.
2.8.2. Ferric Reducing/Antioxidant Power Assay. The deter-
mination of the total antioxidant activity (FRAP assay)
of CLG is a modified method of Benzie and Strain [26].
The stock solutions included 300mM acetate buﬀer (3.1 g
C2H3NaO2·3H2O and 16mL C2H4O2), pH 3.6, 10mM
TPTZ (2, 4, 6-tripyridyl-s-triazine) solution in 40 mMHCl,
and 20mM FeCl3 · 6H2O solution. The fresh working
solution was prepared bymixing 25mL acetate buﬀer, 2.5mL
TPTZ, and 2.5mL FeCl3 · 6H2O. The temperature of the
solution was raised to 37◦C before use. CLG (10 μL) was
allowed to react with 300 μL of the FRAP solution in the dark.
Readings of the coloured product (ferrous tripyridyltriazine
complex) were taken at 593 nm. The standard curve was
linear between 100 and 1000 μMFeSO4. Results are expressed
in μM Fe(II)/g dry mass and compared with that of ascorbic
acid and quercetin.
2.9. Statistical Analysis. The data obtained was statistically
analyzed using one-way ANOVA. This was followed by
Dunnett’s or Tukey’s post hoc tests when the ANOVA
produced significant results. All data were expressed as the
mean ± S.E.M. The tests were performed using GraphPad
Software version 5.01 (GraphPad Software Inc., San Diego,
CA). Diﬀerences are considered significant when P < 0.05.
3. Results
3.1. Cytotoxicity of CLG. The panel of cell lines used in this
study were human hepatocellular carcinoma cells (HepG2),
prostate adenocarcinoma cells (PC3), colon adenocarcinoma
cells (HT-29), non-small-cell lung cancer cells (A549),
and normal hepatic cells (WRL-68). The cytotoxicity assay
(MTT) performed in this study revealed that the CLG had
demonstrated a dose-depended eﬀect on HT-29. The EC50
value (the sample concentration reducing the absorbance of
treated cells by 50% with respect to untreated cells) of CLG
on the viability of HT-29 has been determined to be 79.76±
2.34μg/mL (Table 1). All cells were observed to be resistant
to CLG. Fortunately, CLG did not produce any toxic eﬀects
on normal hepatic cells until the concentration of 200 μg/mL.
Paclitaxel showed high indiscriminate cytotoxicity to all cells
used in this study.
3.2. Chromatin Condensation Assay. We then investigated
apoptosis in cells that had been incubated with CLG using
the DNA staining dyes Hoechst 33342. After a 24-hour
incubation with CGL, the percentage of apoptotic cells was
significantly increased compared with the control (medium
alone) (P < 0.05). Following incubation of cells with CGL
for 72 h, the apoptosis was also significantly increased (P <
0.05). The increased percentage of fluorescent intensity is
the direct representation of chromatin condensation in the
nucleus (Figures 1(a) and 1(b)). Figure 1(c) summarizes the
results of CGL-dependent apoptosis, that is, the percentage
of apoptosis above control levels.
3.3. Colorimetric Assay of Caspase-3. Since HT-29 has shown
remarkable sensitivity to CLG, an in vitro colorimetric assay
of caspase-3 was conducted to assess apoptosis between con-
trol and treated cells. As shown in Figure 2, CLG significantly
(independent t-test, P < 0.05) stimulated caspase-3, the
hallmark enzyme of apoptosis. The level of this enzyme is
higher in treated HT-29 cells as compared to nontreated cells;
this concludes that CLG induces cell death towards human
colon cancer cells, HT-29.
3.4. Gene Expression. To examine whether the apoptotic
eﬀect of CLG is due to intervention with caspase-3-regulated
apoptosis, mRNAs of HT-29 cells were studied using qRT-
PCR. Caspase-3 mRNA level was significantly increased in
cells exposed to CLG compared to levels in control cells
(Figure 3).
3.5. Eﬀect of CLG on Nitric Oxide from RAW 264.7 Ma-
crophage. Stimulation with LPS and IFN-γ led to fortyfold
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Figure 1: Fluorescent photomicrographs of cells stained Hoechst 33342 being treated with with CLG (IC50) for 24 and 48 h. (a) Control, (b)
chromatin condensation in the nucleus (48 h), and (c) quantitative analysis of apoptosis (total nuclear intensity). Statistical significance is
expressed as ∗, P < 0.05.
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Figure 2: The colorimetric assay of caspase-3 in colon adenocar-
cinoma cells (HT-29) treated and untreated with CLG (IC50) for
24 and 48 h. ANOVA showed a significant diﬀerence (∗P < 0.05)
between treated and untreated cells in the activity of caspase-3.
increase in nitrite concentrations in the cell supernatant with
a concentration of 39.76 ± 1.2μM as compared to the basal
level of 1.0±0.05μM in untreated cells (Figure 4). NO release
was eﬀectively inhibited by CLG with an IC50 of 26.5 ±
1.81μM. Following 20 h of treatment and stimulation, CLG
caused a 90% inhibition of NO at 75 μM, without aﬀecting
the cell viability (Figure 5). L-NAME, as a positive control
anti-NO drug, caused an 84% inhibition of NO at 250 μM.
3.6. ORAC Antioxidant Activity Assay. To evaluate the
antioxidant capacity of CLG, ORAC assay was used, and the
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Figure 3: Caspase-3 mRNA expression in HT-29. Cells were treated
with CLG and then incubated with for 24 h. After incubation, cells
were harvested and used real-time RTPCR analysis. Normalization
relative to GAPDH was performed. Results presented in bar graph
are the means ± SD of three independent experiments. The
statistical significance is expressed as ∗, P < 0.05.
potency of this natural compound was compared with the
positive control, quercetin. The area under the curve (AUC)
was calculated for the CLG, trolox, and quercetin. ORAC
results are shown in Table 1. CLG displays considerable
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Figure 4: The eﬀects of CLG on NO production in RAW264.7 cells:
cells were pretreated with the indicated concentrations of CLG, or
the NO inhibitor L-NAME. The cells were stimulated with LPS and
INF or were left untreated. The nitric oxide was measured using
Griess assay. Data is representative of three independent experi-
ments and was analysed using one-way ANOVA. The inhibitory
eﬀect of CLG was significantly diﬀerent from stimulated cells.
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Figure 5: The eﬀects of CLG on RAW264.7 cells’ viability: cells were
pretreated with the indicated concentrations of CLG or were left
untreated. Data is the average of three independent experiments
(±SD) and was analyzed using one-way ANOVA. The statistical
significance is expressed as ∗, P < 0.05.
antioxidant activity. Whereby, this compound at 20 μg/mL
is equivalent to a concentration of 82.5 ± 0.53μM of trolox.
Quercetin at 5 μg/mL is equivalent to a concentration of
160.32± 2.75μM of Trolox.
3.7. FRAP Assay. The total antioxidant activity was deter-
mined using FRAP assay. This assay measures the reduction
of ferric iron (Fe3+) to ferrous iron (Fe2+) in the presence
of antioxidants, which are reductants with half-reaction
reduction potentials above Fe3+/Fe2+. On treatment, CLG
exhibited a significant FRAP value, with a 241±12.5 μmol/L,
while the positive control used in this study exhibited a value
of 350 ± 9.5 and 251 ± 5.7 for ascorbic acid and quercetin,
respectively (Figure 6).
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Figure 6: Ferric reducing/antioxidant power assay. Results are
expressed in μM Fe(II)/g dry mass and compared with that of
ascorbic acid and quercetin. ANOVA. The statistical significance is
expressed as ∗, P < 0.05.
4. Discussion
The cucurbitacins are of great interest because of the wide
range of biological activities they exhibit in plants and
animals [20]. In the present study, we investigated for the
first time the apoptogenic eﬀects of cucurbitacin L 2-O-β-
glucoside (CLG) on cancer cell (HT-29) and the involvement
of reactive oxygen and nitrogen species regulation. Our
results indicate that CLG is more cytoselective to colon
cancer cells than the other tested cancer cells. The inhibitory
eﬀects of CLG on RNS and ROS are suggested to be the
mechanism of apoptogenic eﬀect of this natural compound.
Based on our study, the anti-inflammatory and antioxidant
properties of CLG may be regarded as a key attribute for its
role against colon tumorigenesis.
Nitric oxide (NO) is a free radical gas with important
immune, cardiovascular, and neurological second messenger
functions that is implicated in sepsis, cancer, and inflamma-
tion. This molecule is synthesized from the amino acid L-
arginine by a family of enzymes, the nitric oxide synthases
(NOSs). NO in colonic mucosa is susceptible to manipula-
tion by proinflammatory cytokines [27–30]. The obtained
results suggest that the compound has dose-dependent anti-
inflammatory activities related with their inhibition of NO
production in macrophages without aﬀecting the viability
of these cells. Our results are in line with previous findings
which showed that cucurbitacin compounds are able to
inhibit the production of NO [27, 28].
Anticolorectal cancer agents have an inhibitory eﬀect
on nitrite production in colonic mucosa and could play
an anti-inflammatory role in intestinal inflammation and
malignancies [31]. NO has also been demonstrated to be
involved in the inhibition of apoptosis in a number of
cell types including leukocytes, hepatocytes, trophoblasts,
and endothelial cells such as HT-29 [32]. Generally, the
antiapoptotic eﬀects of NO can be mediated through a
number of mechanisms such as the nitrosylation and
inactivation of many of the caspases including caspase 3.
As shown in Figure 2, CLG significantly (independent t-test,
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P < 0.05) stimulated caspase-3 (protein and gene), the
hallmark enzyme of apoptosis. Previous reports have shown
that the ability of cucurbitacin D to induce apoptosis is
related with its ability to activate caspase-3 in cancer cells
[33]. Earlier, we also observed the onset of apoptosis marked
by the nuclear fragmentation using Hoechst 33342 dye. Both
the morphological assessment of changes in apoptotic nuclei
and the activation of caspase-3 induced by CGL in this study
had validated the presence of involvement of apoptosis in the
cell death occurred.
Although the mechanism by which cucurbitacin glyco-
sides act as antioxidants is not well understood, it is gen-
erally believed that the beneficial properties of cucurbitacin
glycosides are due to their ability to directly interact with
reactive oxygen species [20]. The current study shows for the
first time that CLG is an eﬀective antioxidant when tested
using bothORAC and FRAP assays. These results suggest that
CLG could be used to suppress oxygen cellular metabolites.
Previous data have demonstrated that the cucurbitacin E
glycoside exhibits antioxidant properties, probably through
the involvement of a direct scavenging eﬀect on several free
radicals [20]. On the other hand, NO can freely interact
with oxygen metabolites to yield nitrosating species, and
the formation of nitrosamines may be important in the
development of colorectal cancer in ulcerative colitis. High
levels of nitrosamines have been demonstrated in rectal
dialysates of patients with active inflammatory bowel disease
[12]. Therefore, the obtained results warrant further research
for the clinical application of CLG as chemopreventive agents
for advanced ulcerative colitis patients.
Selective apoptogenesis of potential anticancer drugs
have been reported previously for various chemical entities
with the aid of molecular modelling and structure activity
relationship (SAR) studies [34–36]. Previous SAR study with
five cucurbitacin analogues led to a highly selective STAT3, a
proliferation protein, and cucurbitacin Q; a highly selective
inhibitor of JAK2 activation, cucurbitacin A; three dual
inhibitors, cucurbitacin I, E, and B. From the chemical point
of view, these findings indicate that addition of a single
hydroxyl group to carbon 11 of the cucurbitacins results in
loss of anti-STAT3 activity, whereas a simple conversion of
a carbon 3 carbonyl to a hydroxyl leads to loss of anti-JAK2
activity [37].
In summary, the present study showed that the apopto-
genic eﬀects of cucurbitacin L 2-O-β-glucoside on the tested
cancer cells is selectively directed to HT-29. The suppressive
eﬀects of CLG on reactive oxygen and nitrogen species
regulation are very much correlated to cell death induced
in HT-29. Based on our studies, the anti-inflammatory
and antioxidant eﬀects of CLG may be regarded as a key
attribute for its role against chronic ulcerative colitis and
colon tumorigenesis.
5. Conclusion
Cucurbitacin is one of the constituents of plants used in
folk medicine. Till date, there was no study reporting the
apoptogenic eﬀects of CLG on human colon cancer cells
(HT-29). The current study shows for the first time that the
apoptogenic property of CLG on HT-29 cells is related to the
inhibition of reactive nitrogen and oxygen species eventually
leading to caspase-3-mediated apoptosis. At present, the
pathways related to apoptosis are being studied in our
lab.
Conflict of Interests
The authors declare no conflict of interests.
Acknowledgments
The authors would like to express their utmost gratitude and
appreciation to University of Malaya (HIR Grant F00009-
21001) for providing grant to conduct this study. The
authors are also very grateful to Medicinal and Aromatic
Plants Research Institute (Sudan) for partially sponsoring
this work.
References
[1] M. M. E. Taha, A. B. Abdul, R. Abdullah, T. A. T. Ibrahim,
S. I. Abdelwahab, and S. Mohan, “Potential chemoprevention
of diethylnitrosamine-initiated and 2-acetylaminofluorene-
promoted hepatocarcinogenesis by zerumbone from the
rhizomes of the subtropical ginger (Zingiber zerumbet),”
Chemico-Biological Interactions, vol. 186, no. 3, pp. 295–305,
2010.
[2] M. Bjo¨rkman, I. Klingen, A. N. E. Birch et al., “Phytochemicals
of Brassicaceae in plant protection and human health—
influences of climate, environment and agronomic practice,”
Phytochemistry, vol. 72, no. 7, pp. 538–556, 2011.
[3] D. Il’yasova, L. H. Colbert, T. B. Harris et al., “Circulating
levels of inflammatory markers and cancer risk in the health
aging and body composition cohort,” Cancer Epidemiology
Biomarkers and Prevention, vol. 14, no. 10, pp. 2413–2418,
2005.
[4] C. V. Rao, C. Indranie, B. Simi, P. T. Manning, J. R. Connor,
and B. S. Reddy, “Chemopreventive properties of a selective
inducible nitric oxide synthase inhibitor in colon carcinogen-
esis, administered alone or in combination with celecoxib, a
selective cyclooxygenase-2 inhibitor,” Cancer Research, vol. 62,
no. 1, pp. 165–170, 2002.
[5] M. Takahashi, M. Mutoh, T. Kawamori, T. Sugimura, and
K. Wakabayashi, “Altered expression of β-catenin, inducible
nitric oxide synthase and cyclooxygenase-2 in azoxymethane-
induced rat colon carcinogenesis,” Carcinogenesis, vol. 21, no.
7, pp. 1319–1327, 2000.
[6] C. V. Rao, T. Kawamori, R. Hamid, and B. S. Reddy, “Chemo-
prevention of colonic aberrant crypt foci by an inducible nitric
oxide synthase-selective inhibitor,” Carcinogenesis, vol. 20, no.
4, pp. 641–644, 1999.
[7] C. Luceri, G. Caderni, A. Sanna, and P. Dolara, “Red wine and
black tea polyphenols modulate the expression of cycloxygen-
ase-2, inducible nitric oxide synthase and glutathione-related
enzymes in azoxymethane-induced F344 rat colon tumors,”
Journal of Nutrition, vol. 132, no. 6, pp. 1376–1379, 2002.
[8] C. Bogdan, M. Ro¨llinghoﬀ, and A. Diefenbach, “Reactive oxy-
gen and reactive nitrogen intermediates in innate and specific
immunity,” Current Opinion in Immunology, vol. 12, no. 1, pp.
64–76, 2000.
8 Evidence-Based Complementary and Alternative Medicine
[9] G. Gloire, S. Legrand-Poels, and J. Piette, “NF-κB activation
by reactive oxygen species: fifteen years later,” Biochemical
Pharmacology, vol. 72, no. 11, pp. 1493–1505, 2006.
[10] J. Tian, S. F. Kim, L. Hester, and S. H. Snyder, “S-nitrosyl-
ation/activation of COX-2 mediates NMDA neurotoxicity,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 105, no. 30, pp. 10537–10540, 2008.
[11] S. J. Wimalawansa, “Nitric oxide: new evidence for novel
therapeutic indications,” Expert Opinion on Pharmacotherapy,
vol. 9, no. 11, pp. 1935–1954, 2008.
[12] F. Peyrot and C. Ducrocq, “Potential role of tryptophan
derivatives in stress responses characterized by the generation
of reactive oxygen and nitrogen species,” Journal of Pineal
Research, vol. 45, no. 3, pp. 235–246, 2008.
[13] M. Y. Ibrahim, A. B. H. Abdul, T. A. T. Ibrahim, S. I. AbdelWa-
hab, M. M. Elhassan, and S. Mohan, “Attenuation of cisplatin-
induced nephrotoxicity in rats using zerumbone,” African
Journal of Biotechnology, vol. 9, no. 28, pp. 4434–4441, 2010.
[14] B. E. Okoli, “Wild and cultivated cucurbits in Nigeria,” Eco-
nomic Botany, vol. 38, no. 3, pp. 350–357, 1984.
[15] A. Murakami, S. Jiwajinda, K. Koshimizu, and H. Ohigashi,
“Screening for in vitro anti-tumor promoting activities of
edible plants from Thailand,” Cancer Letters, vol. 95, no. 1-2,
pp. 139–146, 1995.
[16] B. Jayaprakasam, N. P. Seeram, and M. G. Nair, “Anticancer
and antiinflammatory activities of cucurbitacins from Cucur-
bita andreana,” Cancer Letters, vol. 189, no. 1, pp. 11–16, 2003.
[17] E. Attard, M. P. Brincat, and A. Cuschieri, “Immunomod-
ulatory activity of cucurbitacin E isolated from Ecballium
elaterium,” Fitoterapia, vol. 76, no. 5, pp. 439–441, 2005.
[18] J. M. Siqueira, R. R. Peters, A. C. Gazola et al., “Anti-
inflammatory eﬀects of a triterpenoid isolated from Wilbran-
dia ebracteata Cogn,” Life Sciences, vol. 80, no. 15, pp. 1382–
1387, 2007.
[19] R. R. Peters, M. R. Farias, and R. M. Ribeiro-do-Valle, “Anti-
inflammatory and analgesic eﬀects of cucurbitacins from
Wilbrandia ebracteata,” Planta Medica, vol. 63, no. 6, pp. 525–
528, 1997.
[20] T. Tannin-Spitz, M. Bergman, and S. Grossman, “Cucur-
bitacin glucosides: antioxidant and free-radical scavenging
activities,” Biochemical and Biophysical Research Communica-
tions, vol. 364, no. 1, pp. 181–186, 2007.
[21] T. Tannin-Spitz, S. Grossman, S. Dovrat, H. E. Gottlieb,
and M. Bergman, “Growth inhibitory activity of cucurbitacin
glucosides isolated from Citrullus colocynthis on human breast
cancer cells,” Biochemical Pharmacology, vol. 73, no. 1, pp. 56–
67, 2007.
[22] R. Mata, P. Castan˜eda, M. D. R. Camacho, and G. Delgado,
“Chemical studies on Mexican plants used in traditional med-
icine, V. Cucurbitacin glucosides from Cigarrilla mexicana,”
Journal of Natural Products, vol. 51, no. 5, pp. 836–839, 1988.
[23] D. L. Granger, R. R. Taintor, K. S. Boockvar, and J. B. Hibbs,
“Measurement of nitrate and nitrite in biological samples
using nitrate reductase and Griess reaction,” Methods in
Enzymology, vol. 268, pp. 142–151, 1996.
[24] T. Mosmann, “Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity
assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp.
55–63, 1983.
[25] G. Cao, H. M. Alessio, and R. G. Cutler, “Oxygen-radical ab-
sorbance capacity assay for antioxidants,” Free Radical Biology
and Medicine, vol. 14, no. 3, pp. 303–311, 1993.
[26] I. F. F. Benzie and J. J. Strain, “Ferric reducing/antioxidant
power assay: direct measure of total antioxidant activity
of biological fluids and modified version for simultaneous
measurement of total antioxidant power and ascorbic acid
concentration,” Methods in Enzymology, vol. 299, pp. 15–27,
1998.
[27] C. S. Park, H. Lim, K. J. Han et al., “Inhibition of nitric oxide
generation by 23, 24-dihydrocucurbitacin D in mouse peri-
toneal macrophages,” Journal of Pharmacology and Experimen-
tal Therapeutics, vol. 309, no. 2, pp. 705–710, 2004.
[28] H. V. Annegowda, M. N. Mordi, S. Ramanathan, and S. M.
Mansor, “Analgesic and antioxidant properties of ethanolic
extract of Terminalia catappa L. leaves,” International Journal
of Pharmacology, vol. 6, no. 6, pp. 910–915, 2010.
[29] T. Y. Huang, H. C. Chu, Y. L. Lin et al., “Minocycline atten-
uates experimental colitis in mice by blocking expression
of inducible nitric oxide synthase and matrix metallopro-
teinases,” Toxicology and Applied Pharmacology, vol. 237, no.
1, pp. 69–82, 2009.
[30] T. Tanaka, M. Shimizu, H. Kohno et al., “Chemoprevention
of azoxymethane-induced rat aberrant crypt foci by dietary
zerumbone isolated from Zingiber zerumbet,” Life Sciences, vol.
69, no. 16, pp. 1935–1945, 2001.
[31] B. Bonavida, S. Baritaki, S. Huerta-Yepez, M. I. Vega, A. R.
Jazirehi, and J. Berenson, “Nitric oxide donors are a new class
of anti-cancer therapeutics for the reversal of resistance and
inhibition of metastasis,” Nitric Oxide (NO) and Cancer, part
7, pp. 459–477, 2010.
[32] Q. Ma, Z. Wang, M. Zhang et al., “Targeting the L-arginine-
nitric oxide pathway for cancer treatment,” Current Pharma-
ceutical Design, vol. 16, no. 4, pp. 392–410, 2010.
[33] N. Takahashi, Y. Yoshida, T. Sugiura, K. Matsuno, A. Fujino,
and U. Yamashita, “Cucurbitacin D isolated from Trichosan-
thes kirilowii induces apoptosis in human hepatocellular
carcinoma cells in vitro,” International Immunopharmacology,
vol. 9, no. 4, pp. 508–513, 2009.
[34] F. Ciardiello, R. Caputo, R. Bianco et al., “Antitumor eﬀect and
potentiation of cytotoxic drugs activity in human cancer cells
by ZD-1839 (Iressa), an epidermal growth factor receptor-
selective tyrosine kinase inhibitor,” Clinical Cancer Research,
vol. 6, no. 5, pp. 2053–2063, 2000.
[35] S. Fulda and K. M. Debatin, “Sensitization for anticancer
drug-induced apoptosis by betulinic acid,” Neoplasia, vol. 7,
no. 2, pp. 162–170, 2005.
[36] A. Nebbioso, N. Clarke, E. Voltz et al., “Tumor-selective action
of HDAC inhibitors involves TRAIL induction in acute mye-
loid leukemia cells,” Nature Medicine, vol. 11, no. 1, pp. 77–84,
2005.
[37] J. Sun, M. A. Blaskovich, R. Jove, S. K. Livingston, D. Coppola,
and S. M. Sebti, “Cucurbitacin Q: a selective STAT3 activation
inhibitor with potent antitumor activity,” Oncogene, vol. 24,
no. 20, pp. 3236–3245, 2005.
